Consistent with this, we found that 4-OI reduces glycolysis in macrophages expressing or not the pathogenic p.D305N NLRP3 variant, which could potentially contribute to limiting IL-1β production during sterile inflammatory flares in CAPS patients. Here, NLRP3 is linked to cryopyrin-associated periodic syndrome.